-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Talis Biomedical Corp quarterly/annual Revenues history and growth rate from Q1 2021 to Q2 2024.
- Talis Biomedical Corp Revenues for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
- Talis Biomedical Corp Revenues for the twelve months ending June 30, 2024 was $408K, a 85.7% decline year-over-year.
- Talis Biomedical Corp annual Revenues for 2023 was $2.13M, a 55.7% decline from 2022.
- Talis Biomedical Corp annual Revenues for 2022 was $4.81M, a 41.3% decline from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)